Amylyx Pharmaceuticals Inc
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
1.95
-0.03
(-1.515%)
Volume:
1,471,449
52 week range:
1.85 - 30.5
Market Cap:
132.175M
Company Description:
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.